Lei Guo
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 12
-
- MicroRNA in disease regulation 5
- Co-authors
- Qing‐Hai Ye (18 shared papers)Jubo Zhang (9 shared papers)Lianfu Deng (15 shared papers)Ping Huang (16 shared papers)Xiaoqiang Li (7 shared papers)Qi Jin (11 shared papers)Yufei Yan (10 shared papers)Changwei Li (10 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Scientific Reports (3 papers)Journal of Cellular Physiology (3 papers)Cell Death and Disease (3 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lei Guo
102 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 114
- Hepatology 341
- Cancer Research 429
- Rehabilitation 161
- Molecular Medicine 144
- Biochemistry 136
Countries citing papers authored by Lei Guo
This map shows the geographic impact of Lei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Guo more than expected).
Fields of papers citing papers by Lei Guo
This network shows the impact of papers produced by Lei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Guo. The network helps show where Lei Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 185 | |
| 2 | 2017 | 165 | |
| 3 | 2016 | 129 | |
| 4 | 2013 | 117 | |
| 5 | 2016 | 117 | |
| 6 | 2022 | 113 | |
| 7 | 2010 | 96 | |
| 8 | 2013 | 88 | |
| 9 | 2022 | 86 | |
| 10 | 2019 | 82 | |
| 11 | 2014 | 80 | |
| 12 | 2010 | 77 | |
| 13 | Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. | 2019 | 71 |
| 14 | 2016 | 69 | |
| 15 | 2016 | 67 | |
| 16 | 2023 | 67 | |
| 17 | 2016 | 64 | |
| 18 | 2020 | 54 | |
| 19 | 2018 | 53 | |
| 20 | 2012 | 51 |
About Lei Guo
Lei Guo is a scholar working on Hepatology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 103 papers that have together received 3.5k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Spine and Intervertebral Disc Pathology (7 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Glaucoma and retinal disorders (6 papers), Sulfur Compounds in Biology (5 papers), MicroRNA in disease regulation (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Hepatology (341 citations), Cancer Research (429 citations), Rehabilitation (161 citations), Molecular Medicine (144 citations) and Biochemistry (136 citations). Lei Guo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qing‐Hai Ye, Jubo Zhang, Lianfu Deng, Ping Huang, Xiaoqiang Li, Qi Jin, Yufei Yan, Changwei Li, Min Jiang and Hui Kang. Their work appears in journals such as Journal of Medicinal Chemistry, Scientific Reports, Journal of Cellular Physiology, Cell Death and Disease and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.